• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

壳聚糖/羟基磷灰石(HA)/羟丙基甲基纤维素(HPMC)海绵状支架的合成及其作为潜在肺泡骨替代品的评价。

Chitosan/hydroxyapatite (HA)/hydroxypropylmethyl cellulose (HPMC) spongy scaffolds-synthesis and evaluation as potential alveolar bone substitutes.

机构信息

Interdisciplinary Research Centre in Biomedical Materials, COMSATS Institute of Information Technology, Defence Road, Off Raiwind Road, Lahore, 54000, Pakistan.

Institute of Biochemistry and Biotechnology, University of the Punjab, 54590 Lahore, Pakistan.

出版信息

Colloids Surf B Biointerfaces. 2017 Dec 1;160:553-563. doi: 10.1016/j.colsurfb.2017.09.059. Epub 2017 Oct 4.

DOI:10.1016/j.colsurfb.2017.09.059
PMID:29024920
Abstract

Alveolar bone loss is associated with infections and its augmentation is a pre-requisite for the success of dental implants. In present study, we aim to develop and evaluate novel freeze dried doxycycline loaded chitosan (CS)/hydroxyapatite (HA) spongy scaffolds where hydroxypropylmethyl cellulose (HPMC) was added as a crosslinker. Scaffolds displayed compressive strength of 14MPa/cm and 0.34 as elastic response. The interconnected pore diameter was 41-273μm, favorably provided the template supporting cells and transport. An overall 10% degradation was seen after 14day's studies at pH 7.4 in PBS. Doxycycline hyclate, a frequently used drug to counter oral infections, demonstrated an initial burst release (6-8h), followed by a sustain release profile for the remaining 64h. CS/HA/HPMC scaffolds were nontoxic and promoted pre-osteoblast cell viability as seen with live/dead calcein staining after 24h where scaffolds with 10% and 25% HPMC by weight of scaffold had more viable cells. Scaffolds with 10%, 20% and 25% HPMC by weight of scaffold showed efficient cellular adhesion as seen in scanning electron microscopy images (day 8) indicating that pre-osteoblast cells were able to adhere well on the surface and into the porous structure via cytoplasmic extensions. Hoechst 33258 nuclear staining at day 2 and 8 indicated cell proliferation which was further supported byMTT assay at day 2, 4 and 8. Although all scaffolds supported pre-osteoblast cell viability, alkaline phosphatase (ALP) staining demonstrated that upon induction, differentiation was pronounced in case of scaffolds with 10% HMPC scaffolds. Conclusively, these materials having all the required mechanical and biological properties are potential candidates for alveolar bone regeneration.

摘要

牙槽骨丧失与感染有关,其增加是牙种植体成功的前提。在本研究中,我们旨在开发和评估新型冻干盐酸多西环素负载壳聚糖(CS)/羟基磷灰石(HA)海绵状支架,其中添加羟丙基甲基纤维素(HPMC)作为交联剂。支架的压缩强度为 14MPa/cm,弹性响应为 0.34。相互连通的孔径为 41-273μm,有利于细胞和运输的模板支撑。在 pH7.4 的 PBS 中,14 天后的研究中观察到总降解率为 10%。盐酸多西环素是一种常用于治疗口腔感染的药物,在最初的 6-8 小时内表现出快速释放(初始突释),随后在剩余的 64 小时内呈现持续释放的特征。CS/HA/HPMC 支架无毒性,并通过 24 小时后 calcein 染色的活/死细胞染色观察到促进前成骨细胞活力,其中支架重量的 10%和 25%的 HPMC 具有更多的存活细胞。支架重量的 10%、20%和 25%的 HPMC 具有高效的细胞粘附性,如扫描电子显微镜图像(第 8 天)所示,表明前成骨细胞能够通过细胞质延伸很好地粘附在表面和多孔结构上。第 2 天和第 8 天的 Hoechst 33258 核染色表明细胞增殖,在第 2、4 和 8 天的 MTT 测定中进一步得到支持。虽然所有支架都支持前成骨细胞的活力,但碱性磷酸酶(ALP)染色表明,在诱导的情况下,10% HMPC 支架的分化更为明显。总之,这些具有所有必需的机械和生物学特性的材料是牙槽骨再生的潜在候选材料。

相似文献

1
Chitosan/hydroxyapatite (HA)/hydroxypropylmethyl cellulose (HPMC) spongy scaffolds-synthesis and evaluation as potential alveolar bone substitutes.壳聚糖/羟基磷灰石(HA)/羟丙基甲基纤维素(HPMC)海绵状支架的合成及其作为潜在肺泡骨替代品的评价。
Colloids Surf B Biointerfaces. 2017 Dec 1;160:553-563. doi: 10.1016/j.colsurfb.2017.09.059. Epub 2017 Oct 4.
2
Injectable porous nano-hydroxyapatite/chitosan/tripolyphosphate scaffolds with improved compressive strength for bone regeneration.具有改善抗压强度的可注射多孔纳米羟基磷灰石/壳聚糖/三聚磷酸钠支架用于骨再生
Mater Sci Eng C Mater Biol Appl. 2016 Dec 1;69:505-12. doi: 10.1016/j.msec.2016.06.089. Epub 2016 Jun 28.
3
Novel hydroxyapatite/chitosan bilayered scaffold for osteochondral tissue-engineering applications: Scaffold design and its performance when seeded with goat bone marrow stromal cells.用于骨软骨组织工程应用的新型羟基磷灰石/壳聚糖双层支架:支架设计及其接种山羊骨髓基质细胞后的性能。
Biomaterials. 2006 Dec;27(36):6123-37. doi: 10.1016/j.biomaterials.2006.07.034. Epub 2006 Aug 30.
4
Hydroxypropylmethyl cellulose (HPMC) crosslinked chitosan (CH) based scaffolds containing bioactive glass (BG) and zinc oxide (ZnO) for alveolar bone repair.基于羟丙基甲基纤维素(HPMC)交联壳聚糖(CH)的支架,含有生物活性玻璃(BG)和氧化锌(ZnO),用于肺泡骨修复。
Carbohydr Polym. 2018 Aug 1;193:9-18. doi: 10.1016/j.carbpol.2018.03.046. Epub 2018 Mar 22.
5
PHBV/PLLA-based composite scaffolds fabricated using an emulsion freezing/freeze-drying technique for bone tissue engineering: surface modification and in vitro biological evaluation.采用乳液冷冻/冻干技术制备用于骨组织工程的 PHBV/PLLA 基复合支架:表面改性及体外生物学评价。
Biofabrication. 2012 Mar;4(1):015003. doi: 10.1088/1758-5082/4/1/015003. Epub 2012 Jan 18.
6
Bone tissue engineering gelatin-hydroxyapatite/graphene oxide scaffolds with the ability to release vitamin D: fabrication, characterization, and in vitro study.具有释放维生素D能力的骨组织工程明胶-羟基磷灰石/氧化石墨烯支架:制备、表征及体外研究
J Mater Sci Mater Med. 2020 Oct 31;31(11):97. doi: 10.1007/s10856-020-06430-5.
7
Preparation and characterization of bionic bone structure chitosan/hydroxyapatite scaffold for bone tissue engineering.仿生骨结构壳聚糖/羟基磷灰石支架的制备及表征用于骨组织工程。
J Biomater Sci Polym Ed. 2014;25(1):61-74. doi: 10.1080/09205063.2013.836950. Epub 2013 Sep 23.
8
Evaluation of adenoviral vascular endothelial growth factor-activated chitosan/hydroxyapatite scaffold for engineering vascularized bone tissue using human osteoblasts: In vitro and in vivo studies.使用人成骨细胞评估腺病毒血管内皮生长因子激活的壳聚糖/羟基磷灰石支架用于构建血管化骨组织:体外和体内研究
J Biomater Appl. 2014 Nov;29(5):748-60. doi: 10.1177/0885328214544769. Epub 2014 Jul 25.
9
Preparation, characterization and osteoblastic activity of chitosan/polycaprolactone/in situ hydroxyapatite scaffolds.壳聚糖/聚己内酯/原位羟基磷灰石支架的制备、表征及成骨活性
J Biomater Sci Polym Ed. 2012;23(14):1755-70. doi: 10.1163/092050611X597780. Epub 2012 May 8.
10
Chitosan-coated hydroxyapatite and drug-loaded polytrimethylene carbonate/polylactic acid scaffold for enhancing bone regeneration.壳聚糖涂层的羟基磷灰石和载药聚三亚甲基碳酸酯/聚乳酸支架,用于增强骨再生。
Carbohydr Polym. 2021 Feb 1;253:117198. doi: 10.1016/j.carbpol.2020.117198. Epub 2020 Oct 10.

引用本文的文献

1
Investigation of Biodegradation and Biocompatibility of Chitosan-Bacterial Cellulose Composite Scaffold for Bone Tissue Engineering Applications.壳聚糖-细菌纤维素复合支架用于骨组织工程应用的生物降解性和生物相容性研究。
Cells. 2025 May 15;14(10):723. doi: 10.3390/cells14100723.
2
Citrate-modified bacterial cellulose as a potential scaffolding material for bone tissue regeneration.柠檬酸改性细菌纤维素作为骨组织再生的潜在支架材料。
PLoS One. 2024 Dec 31;19(12):e0312396. doi: 10.1371/journal.pone.0312396. eCollection 2024.
3
Applications and interventions of polymers and nanomaterials in alveolar bone regeneration and tooth dentistry.
聚合物和纳米材料在牙槽骨再生及牙科学中的应用与干预措施。
RSC Adv. 2024 Nov 12;14(49):36226-36245. doi: 10.1039/d4ra06092j. eCollection 2024 Nov 11.
4
Synthesis of hydroxyapatite from eggshells wet chemical precipitation: a review.通过湿化学沉淀法从蛋壳中合成羟基磷灰石:综述
RSC Adv. 2024 Jul 8;14(30):21439-21452. doi: 10.1039/d4ra02198c. eCollection 2024 Jul 5.
5
Antibacterial and osteoinductive properties of wollastonite scaffolds impregnated with propolis produced by additive manufacturing.通过增材制造生产的蜂胶浸渍硅灰石支架的抗菌和骨诱导特性
Heliyon. 2023 Dec 18;10(1):e23955. doi: 10.1016/j.heliyon.2023.e23955. eCollection 2024 Jan 15.
6
Functionalized cellulose nanofibrils in carbonate-substituted hydroxyapatite nanorod-based scaffold from long-spined sea urchin () shells reinforced with polyvinyl alcohol for alveolar bone tissue engineering.基于长棘海胆()壳的碳酸盐取代羟基磷灰石纳米棒支架中的功能化纤维素纳米纤维,用聚乙烯醇增强,用于牙槽骨组织工程。
RSC Adv. 2023 Nov 3;13(46):32444-32456. doi: 10.1039/d3ra06165e. eCollection 2023 Oct 31.
7
Synthetic Calcium-Phosphate Materials for Bone Grafting.用于骨移植的合成磷酸钙材料
Polymers (Basel). 2023 Sep 19;15(18):3822. doi: 10.3390/polym15183822.
8
Impact of local drug delivery and natural agents as new target strategies against periodontitis: new challenges for personalized therapeutic approach.局部药物递送和天然药物作为抗牙周炎新靶向策略的影响:个性化治疗方法面临的新挑战。
Ther Adv Chronic Dis. 2023 Sep 13;14:20406223231191043. doi: 10.1177/20406223231191043. eCollection 2023.
9
A Novel Chitosan Composite Biomaterial with Drug Eluting Capacity for Maxillary Bone Regeneration.一种具有药物洗脱能力的新型壳聚糖复合生物材料用于上颌骨再生
Materials (Basel). 2023 Jan 10;16(2):685. doi: 10.3390/ma16020685.
10
Advances in novel therapeutic approaches for periodontal diseases.牙周病新型治疗方法的进展。
BMC Oral Health. 2022 Nov 15;22(1):492. doi: 10.1186/s12903-022-02530-6.